Suppr超能文献

相似文献

1
In vivo mechanisms of vaccine-induced protection against HPV infection.
Cell Host Microbe. 2010 Sep 16;8(3):260-70. doi: 10.1016/j.chom.2010.08.003.
2
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. doi: 10.1093/jnci/djp106. Epub 2009 May 26.
4
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.
Vaccine. 2010 Jun 17;28(28):4478-86. doi: 10.1016/j.vaccine.2010.04.039. Epub 2010 Apr 29.
6
Optimization of multimeric human papillomavirus L2 vaccines.
PLoS One. 2013;8(1):e55538. doi: 10.1371/journal.pone.0055538. Epub 2013 Jan 31.
7
Developments in L2-based human papillomavirus (HPV) vaccines.
Virus Res. 2017 Mar 2;231:166-175. doi: 10.1016/j.virusres.2016.11.020. Epub 2016 Nov 23.
9
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
J Virol. 2022 Jul 13;96(13):e0056622. doi: 10.1128/jvi.00566-22. Epub 2022 Jun 15.

引用本文的文献

3
Scientific approaches to defining HPV vaccine-induced protective immunity.
Int J Cancer. 2025 May 15;156(10):1848-1857. doi: 10.1002/ijc.35345. Epub 2025 Feb 13.
4
A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection.
Med Res Rev. 2025 Mar;45(2):349-425. doi: 10.1002/med.22073. Epub 2024 Aug 26.
5
The role of HR-HPV integration in the progression of premalignant lesions into different cancer types.
Heliyon. 2024 Jul 22;10(15):e34999. doi: 10.1016/j.heliyon.2024.e34999. eCollection 2024 Aug 15.
6
Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study.
NPJ Vaccines. 2024 Aug 13;9(1):146. doi: 10.1038/s41541-024-00941-w.
8
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.
Front Immunol. 2023 Jun 27;14:1183727. doi: 10.3389/fimmu.2023.1183727. eCollection 2023.
9
Antiviral neutralizing antibodies: from in vitro to in vivo activity.
Nat Rev Immunol. 2023 Nov;23(11):720-734. doi: 10.1038/s41577-023-00858-w. Epub 2023 Apr 17.
10
Pseudotyped Virus for Papillomavirus.
Adv Exp Med Biol. 2023;1407:85-103. doi: 10.1007/978-981-99-0113-5_5.

本文引用的文献

1
Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments.
Virology. 2010 May 25;401(1):70-9. doi: 10.1016/j.virol.2010.02.002. Epub 2010 Mar 5.
2
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.
4
New virologic reagents for neutralizing antibody assays.
Curr Opin HIV AIDS. 2009 Sep;4(5):418-25. doi: 10.1097/COH.0b013e32832f011e.
7
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20458-63. doi: 10.1073/pnas.0908502106. Epub 2009 Nov 17.
9
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. doi: 10.1093/jnci/djp106. Epub 2009 May 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验